Tumefactive demyelination: Clinical outcomes, lesion evolution and treatments
Multiple Sclerosis Journal - Experimental, Translational and Clinical · 2019-04 · 5 (2)
DOI: 10.1177/2055217319855755 ↗Kurz gefasst
Fachartikel in der Zeitschrift Multiple Sclerosis Journal - Experimental, Translational and Clinical, online erschienen am 18.06.2019. Verfasst von Staley A Brod und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University of Texas, USA. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Objective
Large demyelinating lesions with possible mass effect (tumefactive multiple sclerosis or tumefactive demyelination) can be mistaken for tumour-like space-occupying lesions suggesting a malignant outcome.
Methods
We reviewed our own experience of multiple sclerosis subjects ( n = 28) with tumefactive demyelination to determine the relationship between clinical outcomes and lesion evolution, clinical outcomes and their relationship to different therapies. Patients with central nervous system demyelinating disease were identified from our database over the last 10 years.
Results
No patient increased in extended disability status scale (EDSS). Overall, lesion regression was associated with improved EDSS. Lesion regression was also associated with therapy versus no therapy. No specific therapy or corticosteroid infusions improved EDSS over the long term. The absence of enhancement on follow up on magnetic resonance imaging portended lesion regression.
Conclusion
Tumefactive demyelination may predict a more benign overall course and is susceptible to traditional immunomodulatory treatments.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, University of Texas, USA.
ORCID-Profile: Staley A Brod
Zitieren
APA
Brod, S. A., Lindsey, J. W., & Nelson, F. (2019). Tumefactive demyelination: Clinical outcomes, lesion evolution and treatments. Multiple Sclerosis Journal - Experimental, Translational and Clinical, 5(2). https://doi.org/10.1177/2055217319855755
Vancouver
Brod SA, Lindsey JW, Nelson F. Tumefactive demyelination: Clinical outcomes, lesion evolution and treatments. Multiple Sclerosis Journal - Experimental, Translational and Clinical. 2019;5(2). doi:10.1177/2055217319855755
BibTeX
@article{Brod2019,
author = {Brod, Staley A and Lindsey, J William and Nelson, Flavia},
title = {Tumefactive demyelination: Clinical outcomes, lesion evolution and treatments},
journal = {Multiple Sclerosis Journal - Experimental, Translational and Clinical},
year = {2019},
volume = {5},
number = {2},
doi = {10.1177/2055217319855755}
}
EUVIMED